CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 202 enrolled
Drug / intervention
Solitaire™ FR devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01327989
NCT01327989N/ACompleted
CompareCT.gov

STAR: Solitaire FR Thrombectomy for Acute Revascularisation

Medtronic Neurovascular Clinical Affairs·observational·Posted Apr 4, 2011·Updated Jan 27, 2017

In Brief

An observational study evaluating Solitaire™ FR device for Stroke, Acute. Completed, enrolled 202 participants across 2 sites.

Detailed Summary

The objective of this study was to obtain prospective clinical data on the safety and efficacy of the Solitaire™ FR device for patients diagnosed with acute ischemic stroke.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke, Acute
CountriesSwitzerland
Collaboratorsev3 International

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 4, 2011
Enrollment StartOct 1, 2010
Primary CompletionOct 1, 2012
Study CompletionJan 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2 yearsPosted 15.2 years ago

Interventions

Solitaire™ FR devicedevice

Mechanical Thrombectomy